BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4942728)

  • 1. The pancreatic -cell recognition of insulin secretagogues. II. Site of action of tolbutamide.
    Hellman B; Sehlin J; Töljedal IB
    Biochem Biophys Res Commun; 1971 Dec; 45(6):1384-8. PubMed ID: 4942728
    [No Abstract]   [Full Text] [Related]  

  • 2. The pancreatic -cell recognition of insulin secretagogues. I. Transport of mannoheptulose and the dynamics of insulin release.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Simon E; Täljedal IB
    Mol Pharmacol; 1972 Jan; 8(1):1-7. PubMed ID: 4551472
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport of L-leucine and D-leucine into pancreatic -cells with reference to the mechanisms of amino acid-induced insulin release.
    Hellman B; Sehlin J; Täljedal IB
    Biochim Biophys Acta; 1972 May; 266(2):436-43. PubMed ID: 4624901
    [No Abstract]   [Full Text] [Related]  

  • 4. The pancreatic -cell recognition of insulin secretagogues. V. Binding and stimulatory action of phlorizin.
    Hellman B; Lernmark A; Sehlin J; Täljedal IB
    Mol Pharmacol; 1972 Nov; 8(6):759-69. PubMed ID: 4565689
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro stimulation of insulin release by non-metabolizable, transport-specific amino acids.
    Christensen HN; Hellman B; Lernmark A; Sehlin J; Tager HS; Täljedal IB
    Biochim Biophys Acta; 1971 Aug; 241(2):341-8. PubMed ID: 4110546
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium uptake by pancreatic -cells as measured with the aid of 45 Ca and mannitol- 3 H.
    Hellman B; Sehlin J; Täljedal IB
    Am J Physiol; 1971 Dec; 221(6):1795-801. PubMed ID: 4941910
    [No Abstract]   [Full Text] [Related]  

  • 7. The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.
    Hellman B; Sehlin J; Täljedal IB
    Diabetologia; 1973 Jun; 9(3):210-6. PubMed ID: 4197746
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 6-aminonicotinamide on insulin release and C-14 glucose oxidation by isolated pancreatic rat islets: difference between glucose, tolbutamide and aminophylline.
    Ammon HP; Steinke J
    Endocrinology; 1972 Jul; 91(1):33-8. PubMed ID: 4260250
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release.
    Charles MA; Lawecki J; Steiner AL; Grodsky GM
    Diabetes; 1976 Apr; 25(4):256-9. PubMed ID: 178555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirogliride: an oral hypoglycemic drug which accelerates glucose usage and insulin secretion by islets of Langerhans.
    Zawalich WS; Weill VA; Matschinsky FM
    Diabetes; 1980 May; 29(5):410-2. PubMed ID: 6991332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolbutamide stimulation of 45Ca fluxes in microdissected pancreatic islets rich in beta-cells.
    Hellman B
    Mol Pharmacol; 1981 Jul; 20(1):83-8. PubMed ID: 7027024
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of priming with D-glucose on insulin secretion from rat pancreatic islets: increased responsiveness to other secretagogues.
    Grill V; Rundfeldt M
    Endocrinology; 1979 Oct; 105(4):980-7. PubMed ID: 89958
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta cell replication in rat pancreatic monolayer cultures. Effects of glucose, tolbutamide, glucocorticoid, growth hormone and glucagon.
    Chick WL
    Diabetes; 1973 Sep; 22(9):687-93. PubMed ID: 4125576
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiologic and pharmacologic influence on insulin secretion].
    Frerichs H; Creutzfeldt W
    Med Klin; 1971 Jun; 66(30):1039-44. PubMed ID: 4328077
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ultrastructural events associated with the action of tolbutamide and glybenclamide on pancreatic B-cells in vivo and in vitro].
    Orci L; Stauffacher W; Renold AE; Beaven D; Lambert A; Rouiller C
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():271-374. PubMed ID: 4906021
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of alloxan on permeability and hexose transport in rat pancreatic islets.
    McDaniel ML; Anderson S; Fink J; Roth C; Lacy PE
    Endocrinology; 1975 Jul; 97(1):68-75. PubMed ID: 1095363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical activity in pancreatic islet cells.
    Dean PM; Matthews EK
    Nature; 1968 Jul; 219(5152):389-90. PubMed ID: 4873864
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study on the effects of a hypoglycemic 2-substituted-2-imidazoline derivative (DG-5128) and tolbutamide on insulin secretion from and insulin synthesis in the isolated rat pancreatic islets.
    Kameda KY; Koyama I; Abiko Y
    Biochim Biophys Acta; 1981 Oct; 677(2):263-8. PubMed ID: 7028134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.